openPR Logo
Press release

Insomnia Treatment Market is reaching US$ 7.5 billion at a CAGR of 5.2% from 2018-2026

06-21-2022 11:38 PM CET | Health & Medicine

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
Insomnia Treatment Market 2022

Insomnia Treatment Market 2022

Insomnia Treatment Market 2022

Insomnia Treatment Market is slated to grow on a decent note, i.e. witness a CAGR of 5.2% from 2018-2026, reaching US$ 7.5 billion by the year 2018-2026. Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on to implement wearable devices and several other integrated applications for catering to healthcare needs. This would continue shortly as well.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/23203

Technological innovations have revolutionized lifestyle, communication, business, travel, and healthcare. The healthcare technology industry is continually improving ways to treat neural-related medical conditions, coupled with a significant understanding of subsequent ramifications and consequences.

On the other hand, the pharmaceutical landscape has also transitioned and opened itself to explore novel scientific approaches and innovative technologies within its core therapeutic areas.

Company Profiles:

Sunovion Pharmaceuticals, Inc.
Natrol, LLC
GlaxoSmithKline Plc.
Sanofi SA
Pfizer Inc.
Boehringer Ingelheim International GmbH
Mallinckrodt
PERNIX Therapeutics
Takeda Pharmaceutical Company Limited
Merck & Co. Inc.
Others.

New Pharmaceutical Innovations to Address Key Concerns for Sleep Medications

In the 32nd Annual Meeting of the Associated Professional Sleep Societies (SLEEP 2018), Eisai Co., Ltd. and Purdue Pharma L.P showed positive results from clinical trials of lemborexant, which is currently being studied for the potential treatment of multiple sleep disorders, especially insomnia. On examining lemborexant for sleep onset, sleep maintenance, and return to sleep latency, it showed favorable results in terms of postural instability and residual effect compared to placebo and zolpidem (Ambien).

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/23203

A number of pharmaceutical companies are setting new breakthroughs in the sleep medications segment to cater to specific and unmet needs of insomnia patients. Such innovations are expected to help improve sleep through the night and also allow patients to function appropriately upon awakening, which has been a growing concern among older adults.

Smart Goggles, Wearable Tracking Devices, & Others Are Here to Stay

Multiple companies in the market are working on wearable devices for insomnia treatment, one of which is smart goggles; patients can now be wearing a pair of smart goggles to sleep off. Recent studies indicate that smart goggles use light and sound stimulations to trigger specific patterns in the brain that would eventually induce sleep. The light emitted by the goggles is of a certain wavelength that stimulates the hypothalamus gland within the brain. This leads to controlled secretion of melatonin, a hormone responsible for sleeping patterns.

Additionally, FDA-approved at-home and wearable tracking devices that monitor brain activity, leg movement, and breathing are becoming more common in the sleep research field. Another 'chemical-free' alternative is telehealth, which involves various ways to communicate with patients about their sleep health. Doctors and researchers are likely to focus on telehealth in near future.

In another research, scientists have discovered that certain cells in the brains of mice, expresses a gene called Lhx6, which promotes sleep. On activation, the Lhx6 gene induces sleep in mice; and awakened mice when deactivated. Moreover, a similar gene is also found in the human hypothalamus gland, and is anticipated to be potentially studied for sleep regulation. It is most likely that the compounds with similar properties as the Lhx6 gene will be incorporated with insomnia drugs, for enhance effectiveness.

New Drug Formulations to Remain a Key Strategy among Pharmaceutical Industries

A recent study by Persistence Market Research indicates that OTC drugs contribute a maximum revenue share in the global insomnia treatment market, due to increasing preference among insomnia patients. To make insomnia treatment drugs more effective and occupy a greater share of revenue in the global market, the development of new drug formulations is foreseen to remain a key strategy among leading pharmaceutical industries.

Besides expanding geriatric population, some of the most common concerns such as dependency, addiction, and residual symptoms will further compel the requirement of transformed insomnia treatment market over the projection period, 2018-2026. The global market for insomnia treatment is expected to be valued at around US$ 7.5 Bn by 2026 end, witnessing steady expansion at 5.2% CAGR over 2018-2027.

While North America holds the substantial revenue share in the global insomnia treatment market, retail pharmacies are the most preferred to buy insomnia treatment drugs.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/23203

Key Questions Answered in the Insomnia Treatment Market Report

How is the Insomnia Treatment market expected to grow over the projected period?

What direction is the Insomnia Treatment market expected to take in terms of volume and value during the forecast period?

What is the impact of macroeconomic factors on the Insomnia Treatment market in future?

What are the key market drivers in the Insomnia Treatment market?

What are significant opportunities and improvement areas for Insomnia Treatment manufacturers?

What are the key developments and trends taking over the Insomnia Treatment market?

Which are the emerging countries that are expected to create significant growth opportunities in the Insomnia Treatment market?

Related Reports-

Sweet Potato Flour Market- https://www.persistencemarketresearch.com/market-research/sweet-potato-flour-market.asp

UK Private Healthcare Market - https://www.persistencemarketresearch.com/market-research/uk-private-healthcare-market.asp

Contact us:

Persistence Market Research          
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About US

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insomnia Treatment Market is reaching US$ 7.5 billion at a CAGR of 5.2% from 2018-2026 here

News-ID: 2658444 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases


More Releases for Insomnia

Global Insomnia Industry Analysis By Geography
Stratistics MRC's Insomnia Market report explains company profiling, key segments, market trends, top players and regional, country-level segments. Insomnia is a common sleep disorder characterized by difficulties in sleep. Insomnia can exist as alone or conjugated with other psychiatric problems. The exact reason for the cause of insomnia is still unknown. It is most common in women and the severity may increase in conditions like postpartum, menopause and pregnancy. Insomnia disorder
Competitive Analysis: Insomnia Market Behaviour 2017 - 2026
A recent study showed that nearly 20% people across the world are sleep-deprived, and this means that there will be more people in the coming years who could be victims of acute or chronic insomnia. This trend is sublime for players in the global insomnia market as there will be a larger audience to cater and of course, the need for producing alternative treatment methods to suit the varying needs
Mattress Sydney – Tips For Preventing Insomnia
Having insomnia? Sleeping on a quality mattress Sydney will improve your situation a lot. Insomnia is a condition in which you have a problem to fall asleep or after falling asleep, you have difficulty keeping that condition. However, it is not a disease, but a symptom. The concept of a good sleep generally differs from person to person. On average, an adult needs 7-8 hours of night sleep for normal functioning
Insomnia Market: Trends and Opportunities 2026
Global Insomnia Market: Brief Account The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases
Insomnia Market Research Report 2026
Global Insomnia Market: Brief Account The world insomnia market is envisaged to recoup promisingly from its drowsy growth in the past with a number of worthwhile and well-timed opportunities to take advantage of. Insomnia drugs could find an application in the treatment of Parkinson and Alzheimer’s disease as sedatives. The younger population can increase the global demand as intensively as the geriatric group with rising stress levels and persisting diseases
Insomnia - US Drug Market: Rising Cases Of Insomnia To Be Biggest Driver
Insomnia is one of the common disorders affected to 35% of the worldwide population. Insomnia is primarily classified into primary and secondary subtypes. The number of people suffering from a sleep disorder, insomnia, is increasing in the United States. In the recent past, the launch of new products and drugs to treat insomnia has been benefiting the U.S. insomnia drugs market. The U.S. insomnia market is classified widely, which enables